Peter Vozzo

Peter spent close to a decade as a sell-side research analyst and nearly 10 years as an investor relations officer with various life sciences companies, MedImmune, and Human Genome Sciences. While at ICR, Peter has successfully guided a wide range of management teams and industry leading companies such as Supernus Pharmaceuticals, Silence Therapeutics, Adamas Pharmaceuticals, Zynerba Pharmaceuticals and Ventus Therapeutics. 

Peter shows clients how to effectively communicate their value proposition to a wide group of relevant investors. His communication programs involve targeting prospective shareholders to broaden investment interest and creating strong relationships with both institutional investors and analysts. 

When he has free time, he enjoys hiking, particularly in the many National Parks the U.S. has to offer, and taking trips to warm beaches in the south.